We Look Forward To Seeing You At The Westin San Diego Gaslamp Quarter!

OIS XV is the comprehensive gathering for the entire eye care ecosystem, spanning retina, glaucoma, anterior segment, drug delivery, and beyond. This day and a half program features innovation showcases, investor spotlights, and strategic discussions that bring together leading startups, global strategics, and clinical experts.

AGENDA - FRIDAY, NOVEMBER 21, 2025

7:30 – 8:25 AM

Check-in and Networking Breakfast

8:25 – 8:30 AM

Welcome & Opening Remarks

Presented By:

Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI - Glaucoma Consultants of Long Island

8:30 - 9:50 AM

New Innovation Showcase

IDE Group | Richard Sokolov, Director IDE Medical Devices
Signal12 | Tom Mitro, President & CEO
Perfuse Therapeutics | Sevgi Gurkan, MD, Founder, CEO and President
Cloudbreak Pharma | Abu Abraham, MD, Chief Medical Officer
CS Pharmaceuticals Limited | Rod Hafner, Chief Development Officer
Eyexora | Theresa Heah, MD, MBA, CEO and Vice Chair
PulseMedica | Nir Katchinskiy, Co-Founder & CEO
Oro Therapeutics | Matt Smith, CEO & Co-Founder
InnSight Technologies | LeAnne Labriola, DO, MBA, Founder & CEO
Qlaris Bio | Barbara Wirostko, MD, FARVO, Co-Founder & CMO
Irenix | Stephen Smith, MD, CEO

9:50 - 10:45 AM

Innovating Together: Accelerating Solutions for Global Ophthalmic Challenges Presented by the Collaborative Community on Ophthalmic Innovation (CCOI)

The Vision That Sparked a Movement: The Story Behind CCOI
Mark S. Blumenkranz, MD
________________________________________
Reinventing Ophthalmic Innovation: Fueling the Engine of Collaborative Progress
Malvina B. Eydelman, MD
________________________________________
Bridging the Gap: Enabling Global Access to Pediatric IOLs Through Regulatory and Clinical Alignment
Natalie Afshari, MD, FACS
________________________________________
Oculomics: Unlocking Systemic Health Insights Through the Eye
Vinit Mahajan, MD, PhD
________________________________________

Equity by Design: Accelerating Global Ophthalmic Innovation Through LMIC-Led Solutions

Daniela Ferrara, MD, PhD

________________________________________
Interoperability in Eye Care: Connecting Data, Devices, and Discovery
Ash Kras, MD
________________________________________
Empowering the Next Generation, Together: CCOI and The Ophthalmic Innovation Program at Stanford
David Myung, MD, PhD

Panelists:
Natalie Afshari, MD, FACS, Professor of Ophthalmology and Chief of Cornea and Refractive Surgery - UC San Diego Shiley Eye Institute
Mark Blumenkranz, MD - Byers Eye Institute at Stanford University School of Medicine
Malvina Eydelman, MD, CEO - Collaborative Community on Ophthalmic Innovation
Daniela Ferrara, MD, MS, PhD, FASRS, CMO - Topcon
Ash Kras, MD, Sydney Eye Hospital Foundation
Vinit Mahajan, MD, PhD, Professor of Ophthalmology, Vice Chair for Research - Stanford University
David Myung, MD, PhD, Associate Professor of Ophthalmology - Byers Eye Institute at Stanford University School of Medicine

Moderated By:
Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI - Glaucoma Consultants of Long Island

10:45 - 11:15 AM

Networking Break

11:15 - 12:10 PM

Drug Delivery Showcase

Valitor | Greg Kunst, CEO
Uneedle | Sven Mentink, Director, Ophthalmology
Everads Therapy | Moshe Weinstein, CEO
Nanodropper | Allisa Song, MD, CEO & Founder
OcuMedic | Keith D. Ignotz, MBA, President & CEO
Re-Vana Therapeutics | Hans Christinger, MBA, Chief Business Officer
Eye-Go | Henrik Nagel, CEO

12:10 - 12:25 PM

Overview of Oculomics

Overview

Presented By:
Daniela Ferrara, MD PhD FASRS, CMO - Topcon

12:25 - 1:00 PM

AI and Diagnostics Showcase

Sanro Health | Ash Kras, MD, Founder & CEO
VIDEANT | Grace Chang, MD, PhD, CEO & Founder
Zilia | Dominic Sauvageau, CTO
ClinOmics.AI | Vinit Mahajan, MD, PhD, Co-founder & Chief Scientific Advisor
Evoq Technologies | Daniel Lindgren, Co-Founder & CEO

1:00 - 1:55 PM

Networking Lunch

1:55 - 2:35 PM

Investor Insights

Participants:
Hannah Chang, MD, PhD, Managing Director - Platanus Ventures
Jeffrey Friedman, MD, PhD, Friedman Bioventure
Garrett Hamontree, Partner - Visionary Ventures
Joe Markson, PhD, Principal - Novo Holdings
James Murray, Managing Member - ExSight Ventures

Moderated By:
Adrienne Graves, PhD, Independent Director, Public and Private Biotech/Pharma Companies - Board Chair, RD Fund - Former CEO, Santen Inc - Former Chair, Iveric Bio

2:35 – 3:30 PM

Regenerative Therapies Showcase

Precise Bio | Lior Shav, Head of Business Development
Claris Biotherapeutics | Clarke Atwell, CEO
Diorasis Therapeutics | Remis Bistras, CEO
Adverum Biotechnologies | Lejla Vajzovic, MD - Duke Eye Center
REGENXBIO | Steve Pakola, MD, CMO
4DMT | Chris Simms, Chief Commercial Officer
Emmecell | Jeffrey Goldberg, MD, PhD, Co-founder and Director, Board of Managers

3:30 – 4:00 PM

Networking Break

4:05 – 4:40 PM

Glaucoma Innovation

Panelists:

Jeffrey Goldberg, MD, PhD, Professor and Chair of Ophthalmology - Byers Eye Institute
Shawn O'Neil, CEO - Vialase
Jai G Parekh, MD, MBA, Chief Commercial Officer - Nordic Pharma Eye Care /Co-Founder, EyeCare Consultants of NJ
Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI - Glaucoma Consultants of Long Island

Moderated By:
Barbara Wirostko, MD, FARVO, CMO & Co-Founder - Qlaris Bio / Co-founder & Medical Advisor - MyEyes / Clinical Adjunct Professor - University of Utah, Moran Eye Center

4:40 – 5:30 PM

OIS Situation Room


Panelists:

Warren Dunnavant II, Managing Director, Investment Banking - H.C. Wainwright & Co
Amy Hopkin, PhD, Director, Search and Evaluation for Eye Care - AbbVie External Innovation
Bill Maughan, PhD, Managing Director, Equity Research - Clear Street
Shannon Spock, Pharmaceutical Search and Evaluation Head, BD&L – Alcon
Kim Smith, Founder & CIO – Ausangate Capital
Luke Zack, PharmD, Senior Director and Global Head of Regulatory Affairs Strategy - Oculis US

Moderated By:
Ram Palanki, PharmD, Executive Vice President & Chief Commercial Officer - REGENXBIO
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

5:30 - 7:00 PM

Networking Reception

AGENDA - SATURDAY, NOVEMBER 22, 2025

7:45 - 8:30 AM

Networking Breakfast

8:30 - 8:35 AM

Opening Remarks

8:35 – 9:40 AM

Anterior Innovation Showcase

ECI Therapeutics | Elan Weiner, CEO
OKYO Pharma | Gary S. Jacob, PhD, CEO
Theialife | Patricia Zilliox, PhD, Advisor
BostonSight | Daniel Brocks, MD, CMO
Azalea Vision | Enrique Vega, CEO & Co-Founder
AdOM Advanced Optical Methods | Stan Miele, CEO
Horizon Surgical Systems | JP Hubschman, MD, PhD, CEO
Opus Genetics | Jay Pepose, MD, PhD, Chief Medical Officer
Stuart Therapeutics | Eric Schlumpf, President & CEO

9:40 - 10:15 AM

Refractive Renaissance: The Next Wave in Presbyopia and Accommodative Solutions

Panelists:
Milton Hom, OD - Canyon City Eye Care
Alex Lopez, COO - Ace Vision Group
Eef Schimmelpennink, President & CEO - Lenz Therapeutics
Eric Weinberg, Co-President and Chief Commercial Officer - RxSight

Moderated By:
Ehsan Sadri, MD, Founder - Visionary Eye Institute

10:15- 10:45 AM

Morning Networking Break

10:45 - 12:05 PM

Retina Innovation Showcase

AiViva BioPharma | Diane Tang-Liu, PhD, President & CEO
Oculis | Riad Sherif, MD, CEO
Galimedix Therapeutics | Alexander Gebauer, MD, PhD, Executive Chairman
Neurotech Pharmaceuticals | Rich Small, CEO
FELIQS | Kenichiro Kuninobu, PhD, Co-Founder & CEO
Ocudyne | Jeff Franco, CEO
Ripple Therapeutics | Tom Reeves, Co-founder, President & CEO
Novaliq | Christian Roesky, PhD, CEO
ForwardVue | Bob Katz, CEO
Surrozen | Dan Chao, MD, PhD, Vice President and Head of Clinical Development
MacuTherm | Jan Tode, MD, CMO

12:05 – 12:40 PM

The Future Outlook of Dry AMD: One Disease or Many?

Panelists:

Michael Ackermann, PhD, Founder & CEO - Osanni Bio
Mayssa Attar, PhD, SVP, Pharmaceutical and Consumer R&D Head - Bausch + Lomb
Brian Culley, CEO - Lineage Cell Therapeutics
Jeff Franco, CEO - Ocudyne
Baruch Kuppermann, MD, PhD, Steinert Professor and Chair of the Department of Ophthalmology, and Director of the Gavin Herbert Eye Institute - University of California
Melissa Jones, PhD, Lead Clinical Scientist - Genentech

Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Executive Chairman - Eyconis / Senior Advisor - HealthQuest Capital Management

12:40 - 1:15 PM

Redefining Value: From Innovation to Impact

Panelists:

Kirsten Arndt-Schmitz, Global Development CMC MH, EH and EA - Boehringer Ingelheim Pharma GmbH & Co. KG
Gordon Bethwaite, Head of Marketing, Eye Care, Viatris
Wayne Caulder, VP & GM, Surgical (US/Canada), Bausch + Lomb
Doug Faunce, PhD, Executive Director - Head of Search and Evaluation for Eye Care, AbbVie Ventures
David LeCause, Former Vice President Allergan Eye Care Business Unit; Strategic Advisor - Ophthalmic Pharmaceuticals I Biotech I Drug Delivery I Med Device

Moderated By:
Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI - Glaucoma Consultants of Long Island

1:15 - 1:25 PM

Closing Remarks